| Cat. No. |
Product Name |
Information |
| PC-23122 |
FUT8 Inhibitor 40
FUT8 inhibitor
|
FUT8 Inhibitor 40 is a selective, cell-active inhibitor of α-1,6-fucosyltransferase (FUT8), inhibits FUT8 without inhibiting other FUTs. |
| PC-23103 |
Enavermotide
524060-93-3
|
Enavermotide (UCP2) is a telomerase-derived CD4 epitope peptide, effectively binds to most commonly found human MHC classII alleles, an immunological agent for active immunization. |
| PC-23092 |
Leramistat
Mitochondrial complex 1 inhibitor
|
Leramistat (HMC-C-01-A, MBS2320) is a mitochondrial complex 1 inhibitor, inhibits inhibits ATP production in Thp1 human monocytes with IC50 of 0.63 uM. |
| PC-23084 |
Omramotide
|
Omramotide is an immunological agent for active immunization (antineoplastic), elicits a strong immune response. |
| PC-23068 |
Azalanstat
HO-1 inhibitor
|
Azalanstat (RS-21607) is a selective cytochrome P450 enzyme lanosterol 14 alpha-demethylase cytochrome P450 enzyme lanosterol 14 alpha-demethylase (LDM), inhibits heme oxygenase 1 (HO-1, IC50=5.3 uM), shows cholesterol-lowering activity. |
| PC-23067 |
CDD-3290
PSA inhibitor
|
CDD-3290 is a specific small molecule inhibitor of prostate-specific antigen (PSA; KLK3) with Ki of 216 nM. |
| PC-23061 |
Sucantomotide
Immunogenic compound
|
Sucantomotide is a (poly)peptide and Immunogenic compound comprising an epitope of IL13RA2, BIRC5 and/or FOXM1 for prevention and treatment of cancer, by cancer immunotherapy. |
| PC-23054 |
Vamagloxistat sodium salt
Glycolate oxidase inhibitor
|
Vamagloxistat (BBP-711) sodium salt is a small molecule inhibitor of glycolate oxidase (GOX, GO) for primary hyperoxaluria type 1 and recurrent kidney stone formers. |
| PC-23053 |
Vamagloxistat
Glycolate oxidase inhibitor
|
Vamagloxistat (BBP-711) is a small molecule inhibitor of glycolate oxidase (GOX, GO) for primary hyperoxaluria type 1 and recurrent kidney stone formers. |
| PC-23045 |
EN300
GPRC6A agonist
|
EN300 is a small ligand agonist for GPRC6A, stimulates ERK phosphorylation and cAMP accumulation with EC50 of 2.331 and 3.448 mM, respectively. |
| PC-23025 |
GSDMD agonist DMB
Gasdermin D agonist
|
GSDMD agonist DMB is a direct and selective gasdermin D (GSDMD) agonist, activates GSDMD pore formation to trigger liposome leakage with EC50 of 0.7 uM, activates GSDMD pore formation and pyroptosis without cleaving GSDMD. |
| PC-23021 |
SRSF10 inhibitor 1C8
SRSF10 inhibitor
|
SRSF10 inhibitor 1C8 is a specific small molecule inhibitor of SRSF1, alters splicing regulation mediated by SRSF10, shows strong anti-HIV-1 potency against a variety of clinical strains in vitro. |
